Clorazepate Dipotassium
- Product NDC
- 72603-114
- 11-digit product format
- 726030114
- Labeler code
- 72603
- Product ID
- 72603-114_258be954-8e31-2be4-e063-6394a90a78ca
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Clorazepate Dipotassium
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- NORTHSTAR RX LLC
- Application
- ANDA075731
- Marketing category
- ANDA
- Marketing start
- 2022-10-24
- Substance
- CLORAZEPATE DIPOTASSIUM
- Active strength
- 15 mg/1
- Pharmacologic classes
- Benzodiazepine [EPC], Benzodiazepines [CS]
- DEA schedule
- CIV
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Clorazepate Dipotassium
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| CLORAZEPATE DIPOTASSIUM | 15 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 63FN7G03XY |
| Rxcui | 197464, 197465, 197466 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 72603-114-01 | Clorazepate Dipotassium | 100 in 1 BOTTLE | TABLET | 100 | | 4 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 72603-114 | CLORAZEPATE DIPOTASSIUM TABLET [NORTHSTAR RX LLC] | 4 | Current NDC, Legacy NDC, 1 package rows | 20241030_fb5c9e98-02b2-4c36-b436-25b58fe3c7d5.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 72603-114-01 | 72603011401 | 100 TABLET in 1 BOTTLE (72603-114-01) | 100 tablet | 2022-10-24 | 0000-00-00 | No | No | Current |